Table 4. Correlations of HAM-D21 Score, Hemorheologic Measures and WBC Count in MDD Subjects (N = 146).
Hemorheologic Measures before Treatment | HAM-D21 Score before Treatment | Change in Hemorheologic Measures with treatment | Change in HAM-D21 Score | ||
r | p † | r | p † | ||
RBC count −106/µL | 0.18 | 0.027 | RBC count −106/µL | 0.22 | 0.008 |
HGB – g/dL | 0.14 | 0.105 | HGB – g/dL | 0.18 | 0.027 |
HCT −% | 0.24 | 0.003 | HCT −% | 0.22 | 0.008 |
TSP – g/dL | 0.26 | 0.002 | TSP – g/dL | 0.14 | 0.086 |
Albumin – g/dL | 0.22 | 0.009 | Albumin – g/dL | 0.13 | 0.115 |
WBV – cP | 0.29 | <0.001 | WBV – cP | 0.21 | 0.010 |
Plasma volume¶ | 0.20 | 0.017 | |||
WBC count −106/µL | 0.21 | 0.010 | WBC count −106/µL | 0.23 | 0.007 |
p was based on Spearman partial correlation by controlling for age and gender.
Plasma volume change % after treatment based on the method provided by Dill and Costill.27